Insider filing · VCEL
Jonathan Mark Hopper
Chief Medical Officer
profile →
Vericel Corporation
VCEL · Healthcare · 46 filings in 24 months
ticker →
Jonathan Mark Hopper sold $401K of Vericel (VCEL)
Executed Jun 2 2025, disclosed Jun 4 2025, 2 days later.
Value, as filed
$401K
10,000 sh × $40.09
Executed
Jun 2 2025
the trade date, as filed
Disclosed
Jun 4 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JHJonathan Mark Hopper (Chief Medical Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Vericel Corporation (VCEL). The largest single filing was $450K of VCEL (10,000 sh across 2 lots, as filed), executed Jun 26.
The name
VCELHealthcare · Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of c…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jonathan Mark Hopper in VCEL
VCELSALE
Vericel Corporation
$450K10,000 sh across 2 lots
Exec Jun 26
Filed Jun 30 · 5:30 PM ET VCELSALE Vericel Corporation $153K
4,375 sh × $35.00
Exec Jun 2
Filed Jun 4 · 5:30 PM ET VCELSALE Vericel Corporation $122K
3,472 sh × $35.00
Exec Apr 2
Filed Apr 6 · 5:30 PM ET VCELSALE Vericel Corporation $358K
10,000 sh × $35.77
Exec Sep 2 2025
Filed Sep 3 2025 · 5:30 PM ET VCELSALE Vericel Corporation $495K
10,000 sh × $49.53
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET VCELSALE Vericel Corporation $587K
10,000 sh × $58.72
Exec Dec 2 2024
Filed Dec 3 2024 · 5:30 PM ET